1. P227 Efficacy And Safety Of Budesonide–formoterol (bf) Spiromax® In Adults And Adolescents With Asthma: Randomised Comparison With Bf Turbuhaler®. (10th November 2014) Authors: Virchow, JC; Gopalan, G; Rodriguez-Roisin, R; Shu, Y Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P229 Once-daily Tiotropium Respimat® As Add-on To At Least Medium- To High-dose Ics, With Or Without Laba, Improves Lung Function In Patients With Symptomatic Asthma, Independent Of Allergic Status. (10th November 2014) Authors: Dahl, R; Casale, T; Pizzichini, E; Vandewalker, M; Virchow, JC; Engel, M; Sigmund, R; Moroni-Zentgraf, P; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P7 Assessing the intuitive ease of use of a novel dry powder inhaler, the Forspiro™ device, for asthma and COPD. (19th November 2012) Authors: Jones, S; Weuthen, T; Harmer, QJ; Virchow, JC Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗